Valeant Will Release Third-Quarter 2017 Financial Results On November 7

Published: Oct 03, 2017

LAVAL, Quebec, Oct. 3, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") will release its third-quarter 2017 financial results on Tuesday, Nov. 7, 2017. Valeant will host a conference call and live web cast at 8:00 a.m. EST to discuss the results and provide a business update. All materials will be made available on the investor relations section of the Valeant web site prior to the start of the call.

Conference Call Details


Tuesday, Nov. 7, 2017


8:00 a.m. EST


Participant Event Dial-in: 

(844) 428-3520 (North America)

(409) 767-8386 (International) 

Participant Passcode:


Replay Dial-in:

(855) 859-2056 (North America)

(404) 537-3406 (International) 

Replay Passcode:

91700211 (replay available until Jan. 7, 2018)

About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at

Investor Contact:

Media Contact:

Arthur Shannon

Lainie Keller

(514) 856-3855

(908) 927-0617

(877) 281-6642 (toll free)

Valeant Pharmaceuticals International, Inc. (PRNewsFoto/Valeant Pharmaceuticals International, Inc.) (PRNewsFoto/)


View original content with multimedia:

SOURCE Valeant Pharmaceuticals International, Inc.

Back to news